Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Determining the mode of Galectin1/HOXA5 interaction in glioma stem cells

EF 2022-23

Résumé
Brain tumour stem cells (BTSCs) are central players in glioblastoma resistance to therapy. The LGALS1 gene which encodes for Galectin1, a carbohydrate binding protein, is a key player in regulating BTSC self-renewal and GB resistance to therapy via interaction with HOXA5. Here, we employed the balanced prediction method of the protein–protein docking to predict the interacting mode between Galectin1 and HOXA5. Our analysis suggests that Galectin1 monomer interacts with homeobox domain of HOXA5, which impedes the interaction between the homeobox domain of HOXA5 and DNA. In contrast, interaction of Galectin1 homodimer and the N-terminal region of HOXA5 facilitates or stabilizes the homeobox domain of HOXA5 to bind DNA. We generated a mutant Galectin1 that cannot form dimers in which we have substituted the Cys at position 2 for a Ser residue and the Val at position 5 for an Asp residue. According to our predictions on functional domains in HOXA5 by Pfam, we also generated functional domain deletion mutants of HOXA5. Using wild type (dimer) and mutant (monomer) Galectin1, and deletion-mutant proteins of HOXA5, we will conduct protein binding assays to validate this model and to further investigate the role of galectin1 monomers and dimers in regulation of HOXA5 transcriptional activity, BTSC self-renewal and tumour resistance to therapy. Future studies will focus on how HOXA5 phosphorylation (Y45, Y49, S55 and S59) impacts its interaction with galectin1 and subsequent binding to the negatively charged DNA. Together, these studies will unravel the underlying molecular mechanisms of BTSC regulation by HOXA5.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486238
Name
Popatia Alyanna M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the mode of Galectin1/HOXA5 interaction in glioma stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Tumour Stem Cells; Dimers; Glioblastoma; Homeobox Domain; Hoxa5; Lgals1/Galectin1; Monomers; Phosphorylation; Proliferation; Tumourigenesis
Abstract
Brain tumour stem cells (BTSCs) are central players in glioblastoma resistance to therapy. The LGALS1 gene which encodes for Galectin1, a carbohydrate binding protein, is a key player in regulating BTSC self-renewal and GB resistance to therapy via interaction with HOXA5. Here, we employed the balanced prediction method of the protein–protein docking to predict the interacting mode between Galectin1 and HOXA5. Our analysis suggests that Galectin1 monomer interacts with homeobox domain of HOXA5, which impedes the interaction between the homeobox domain of HOXA5 and DNA. In contrast, interaction of Galectin1 homodimer and the N-terminal region of HOXA5 facilitates or stabilizes the homeobox domain of HOXA5 to bind DNA. We generated a mutant Galectin1 that cannot form dimers in which we have substituted the Cys at position 2 for a Ser residue and the Val at position 5 for an Asp residue. According to our predictions on functional domains in HOXA5 by Pfam, we also generated functional domain deletion mutants of HOXA5. Using wild type (dimer) and mutant (monomer) Galectin1, and deletion-mutant proteins of HOXA5, we will conduct protein binding assays to validate this model and to further investigate the role of galectin1 monomers and dimers in regulation of HOXA5 transcriptional activity, BTSC self-renewal and tumour resistance to therapy. Future studies will focus on how HOXA5 phosphorylation (Y45, Y49, S55 and S59) impacts its interaction with galectin1 and subsequent binding to the negatively charged DNA. Together, these studies will unravel the underlying molecular mechanisms of BTSC regulation by HOXA5.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Popatia, Alyanna M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~